Ginsenoside Supplement Redsenol-1 Plus Gains Recognition in National Cancer Institute's Drug Dictionary
TL;DR
Redsenol-1 Plus's unique rare ginsenosides give it an advantage over conventional ginseng supplements, making it a standout in the market.
Redsenol-1 Plus is defined in the NCI Drug Dictionary as an oral herbal supplement with sixteen rare ginsenosides derived from ginseng.
Redsenol-1 Plus's potential in oncology and supportive care showcases Canada Royal Enoch Phytomedicine's commitment to advancing cancer research.
Redsenol-1 Plus features highly bioactive and absorbable rare ginsenosides, setting it apart in the ginseng supplement industry.
Found this article helpful?
Share it with your network and spread the knowledge!
A novel ginsenoside supplement, Redsenol-1 Plus, has been officially recognized by the National Cancer Institute (NCI) through its inclusion in the prestigious Drug Dictionary. The supplement, developed by Canada Royal Enoch Phytomedicine, stands out as the only product in its category to receive this significant acknowledgment.
The NCI Drug Dictionary listing provides a technical definition of Redsenol-1 Plus, detailing its composition of sixteen rare ginsenosides. Unlike traditional ginseng supplements that contain primarily large-molecule ginsenosides, this product features a highly bioactive profile with 20% rare ginsenoside concentration, compared to the standard 4% in conventional extracts.
The supplement's inclusion represents more than a bureaucratic milestone. It signals potential advancements in cancer supportive care, particularly in addressing cancer-related fatigue. The company is currently conducting a rigorous, triple-blind, placebo-controlled clinical trial to evaluate the supplement's efficacy in mitigating symptoms experienced by cancer patients during treatment.
Dr. Peihua Yu, the company's founder and CEO, emphasized the significance of the standardized definition, noting the importance of advancing scientific understanding of ginsenoside applications in cancer-related conditions.
The development underscores the growing scientific interest in plant-based compounds and their potential therapeutic applications, particularly in oncology support. By offering a more concentrated and bioavailable ginsenoside supplement, Canada Royal Enoch Phytomedicine is pushing the boundaries of natural health product research.
Curated from 24-7 Press Release
